Literature DB >> 24325415

Finding and filling the gaps in the evidence with high quality clinical trials - the experience of one Cochrane Review Group.

Nikki Jahnke1, Tracey Remmington, Alan R Smyth.   

Abstract

The Cochrane Cystic Fibrosis and Genetic Disorders Group publishes systematic reviews of randomized trials for many genetic disorders. Given the rarity of these disorders, there are often few relevant trials to be included. Therefore, it is common for the reviews to be 'empty' and unable to present evidence which aids decision-making in clinical practice. However, we do not regard this as negative; rather we see this as a challenge and an opportunity to influence the research agenda. We have several reviews which clearly illustrate the cycle of assessing the evidence base, identifying the lack of data, generating high quality research and incorporating the resulting data into the original systematic review.
© 2013 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Cystic Fibrosis; randomized trials; systematic review

Mesh:

Year:  2013        PMID: 24325415     DOI: 10.1111/jebm.12073

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  1 in total

1.  The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers.

Authors:  Nicola J Rowbotham; Sherie Smith; Paul A Leighton; Oli C Rayner; Katie Gathercole; Zoe C Elliott; Edward F Nash; Tracey Daniels; Alistair J A Duff; Sarah Collins; Suja Chandran; Ursula Peaple; Matthew N Hurley; Keith Brownlee; Alan R Smyth
Journal:  Thorax       Date:  2017-08-04       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.